List of works - Mathias Vormehr

A liposomal RNA vaccine inducing neoantigen-specific CD4+ T cells augments the antitumor activity of local radiotherapy in mice

scientific article published on 22 June 2020

A non-functional neoepitope specific CD8+ T-cell response induced by tumor derived antigen exposure in vivo

scientific article published on 24 December 2018

A transplantable tumor model allowing investigation of NY-BR-1-specific T cell responses in HLA-DRB1*0401 transgenic mice

scientific article published on 13 September 2019

Actively personalized cancer vaccines--the step into clinical application

article by B P Kloke et al published 1 January 2016 in Die Pharmazie

An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma

scientific article published on 29 July 2020

BNT162b vaccines protect rhesus macaques from SARS-CoV-2

scientific article published in 2021

BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans

scientific article published on 27 May 2021

CIMT 2014: Next waves in cancer immunotherapy--report on the 12th annual meeting of the Association for Cancer Immunotherapy: May 6–8 2014, Mainz, Germany

scientific article published on January 2014

CIMT 2015: The right patient for the right therapy - Report on the 13th annual meeting of the Association for Cancer Immunotherapy

scientific article published on 17 July 2015

CIMT 2016: Mechanisms of efficacy in cancer immunotherapy - Report on the 14th Annual Meeting of the Association for Cancer Immunotherapy May 10-12 2016, Mainz, Germany.

scientific article published on 19 July 2016

CIMT 2017: Anniversary symposium - Report on the 15th CIMT Annual Meeting of the Association for Cancer Immunotherapy

scientific article published on 28 August 2017

COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T-cell responses

scientific article published on 30 September 2020

Concurrent human antibody and TH1 type T-cell responses elicited by a COVID-19 RNA vaccine

preprint

Dexamethasone premedication suppresses vaccine-induced immune responses against cancer

scientific article published on 13 May 2020

Discovery and Subtyping of Neo-Epitope Specific T-Cell Responses for Cancer Immunotherapy: Addressing the Mutanome.

scientific article published in January 2017

Erratum: Mutant MHC class II epitopes drive therapeutic immune responses to cancer

scientific article published in Nature

Harnessing Tumor Mutations for Truly Individualized Cancer Vaccines

scientific article published on 01 January 2019

Intravenous delivery of the toll-like receptor 7 agonist SC1 confers tumor control by inducing a CD8+ T cell response

scientific article published on 19 April 2019

Multi-Omics Characterization of the 4T1 Murine Mammary Gland Tumor Model

scientific article published on 23 July 2020

Mutanome Engineered RNA Immunotherapy: Towards Patient-Centered Tumor Vaccination

scientific article

Mutanome directed cancer immunotherapy

scientific article published on 21 December 2015

Mutant MHC class II epitopes drive therapeutic immune responses to cancer

scientific article published on 22 April 2015

Personalized Neo-Epitope Vaccines for Cancer Treatment

scientific article published on 01 January 2020

Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer

scientific article published on 5 July 2017

Publisher Correction: COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses

correction of a scholarly article

Steatohepatitis Impairs T cell-directed Immunotherapies Against Liver Tumors in Mice